NAD(P)H: Quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: A meta-analysis

Tumor Biology

Volumn 34, Issue 6, 2013, Pages 3967-3979

  Lou, Yuqing ^a   Li, Rong ^a   Xiong, Liwen ^a   Gu, Aiqin ^a   Shi, Chunlei ^a   Chu, Tianqing ^a   Zhang, Xueyan ^a   Gu, Ping ^a   Zhong, Hua ^a   Wen, Shaojun ^b   Han, Baohui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Lung cancer; Meta analysis; NQO1; Single nucleotide polymorphism

Indexed keywords

REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

AFRICAN AMERICAN; ALLELE; ARTICLE; ASIAN; CANCER RISK; CAUCASIAN; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HISPANIC; HUMAN; LUNG SMALL CELL CANCER; NQO1 GENE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

EID: 84891488706     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-0985-7     Document Type: Article

References (50)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63:11-30.
2. Bray FI, Weiderpass E. Lung cancer mortality trends in 36 European countries: secular trends and birth cohort patterns by sex and region 1970-2007. Int J Cancer. 2010;126:1454-66.
3. National Comprehensive Cancer Network. NCCN Non-Small Cell Lung Cancer USA. NCCN clinical practice guidelines in oncology: non-small cell lung cancer V.2.2013.
4. National Comprehensive Cancer Network. NCCN Small Cell Lung Cancer USA. NCCN clinical practice guidelines in oncology: small cell lung cancer V.1.2014.
5. Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: looking to the future. J Clin Oncol. 2005;23:3175-85.
6. Kiyohara C, Yoshimasu K, Takayama K, Nakanishi Y. NQO1, MPO, and the risk of lung cancer: a HuGE review. Genet Med. 2005;7:463-78.
7. Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG. NAD(P)H:quinine oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med. 2002;4:62-70.
8. Misra V, Grondin A, Klamut HJ, Rauth AM. Assessment of the relationship between genotypic status of a DT-diaphorase point mutation and enzymatic activity. Br J Cancer. 2000;83:998-1002.
9. Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer. 1995;72:555-61.
10. Woolf B. On estimating the relation between blood group and disease. Ann Hum Genet. 1955;19:251-3.
11. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127:820-6.
12. Petitti D. Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press; 1994. p. 15-20.
13. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-34.
14. Lin YH, Lu XL, Shao M, Liang YR, Li YJ. NAD(P)H: quinone oxidoreductase gene polymorphism and susceptibility of lung cancer. Ai Zheng. 2000;19:450-2 (in Chinese).
15. Timofeeva M, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, et al. Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer. Int J Cancer. 2010;127:1547-61.
16. Cote ML, Yoo W, Wenzlaff AS, Prysak GM, Santer SK, Claeys GB, et al. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis. 2009;30:626-35.
17. Eom SY, Zhang YW, Kim SH, Choe KH, Lee KY, Park JD, et al. Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans. Cancer Causes Control. 2009;20:137-45.
18. Vineis P, Veglia F, Garte S, Malaveille C, Matullo G, Dunning A, et al. Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Ann Oncol. 2007;18:1230-42.
19. Yang M, Choi Y, Hwangbo B, Lee JS. Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung Cancer. 2007;57:135-42.
20. Lawson KA, Woodson K, Virtamo J, Albanes D. Association of the NAD(P)H:quinone oxidoreductase (NQO1) 609C- > T polymorphism with lung cancer risk among male smokers. Cancer Epidemiol Biomarkers Prev. 2005;14:2275-6.
21. Chan EC, Lam SY, Fu KH, Kwong YL. Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer Genet Cytogenet. 2005;162:10-20.
22. Skuladottir H, Autrup H, Autrup J, Tjoenneland A, Overvad K, Ryberg D, et al. Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years: a pooled study of lung cancer patients in Denmark and Norway. Lung Cancer. 2005;48:187-99.
23. Sørensen M, Autrup H, Tjønneland A, Overvad K, Raaschou-Nielsen O. Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer Lett. 2005;221:185-90.
24. Saldivar SJ, Wang Y, Zhao H, Shao L, Lin J, Spitz MR, et al. An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutat Res. 2005;582:71-8.
25. Liang GY, Pu YP, Yin LH. Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China. Yi Chuan. 2004;26:584-8 (in Chinese).
26. Bock CH, Wenzlaff AS, Cote ML, Land SJ, Schwartz AG. NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study. Carcinogenesis. 2005;26:381-6.
27. Lan Q, Mumford JL, Shen M, Demarini DM, Bonner MR, He X, et al. Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis. 2004;25:2177-81.
28. Alexandrie AK, Nyberg F, Warholm M, Rannug A. Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population. Cancer Epidemiol Biomarkers Prev. 2004;13:908-14.
29. Lin P, Hsueh YM, Ko JL, Liang YF, Tsai KJ, Chen CY. Analysis of NQO1, GSTP1, and MnSOD genetic polymorphisms on lung cancer risk in Taiwan. Lung Cancer. 2003;40:123-9.
30. Sunaga N, Kohno T, Yanagitani N, Sugimura H, Kunitoh H, Tamura T, et al. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev. 2002;11:730-8.
31. Hamajima N, Matsuo K, Iwata H, Shinoda M, Yamamura Y, Kato T, et al. NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol. 2002;7:103-8.
32. Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC. Polymorphisms in the NAD(P)H: quinone oxidoreductase gene and small cell lung cancer risk in a UK population. Lung Cancer. 2001;34:177-83.
33. Yin L, Pu Y, Liu TY, Tung YH, Chen KW, Lin P. Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP1A1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing. China Lung Cancer. 2001;33:133-41.
34. Xu LL, Wain JC, Miller DP, Thurston SW, Su L, Lynch TJ, et al. The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior. Cancer Epidemiol Biomarkers Prev. 2001;10:303-9.
35. Chen H, Lum A, Seifried A, Wilkens LR, Le Marchand L. Association of the NAD(P)H:quinone oxidoreductase 609C- > T polymorphism with a decreased lung cancer risk. Cancer Res. 1999;59:3045-8.
36. Wiencke JK, Spitz MR, McMillan A, Kelsey KT. Lung cancer in Mexican-Americans and African-Americans is associated with the wild-type genotype of the NAD(P)H: quinone oxidoreductase polymorphism. Cancer Epidemiol Biomarkers Prev. 1997;6:87-92.
37. Benhamou S, Voho A, Bouchardy C, Mitrunen K, Dayer P, Hirvonen A. Role of NAD(P)H: quinone oxidoreductase polymorphism at codon 187 in susceptibility to lung, laryngeal and oral/pharyngeal cancers. Biomarkers. 2001;6:440-7.
38. Demirkan A, Vural B, Üstüner Z, Uygun K, Açikalin BÖ, Derin D, et al. CYP1A1, GSTM1 and NQO1 gene polymorphisms: genetic risk factors for small cell lung cancer. Turkish J Cancer. 2005;35:171-6.
39. Lin P, Wang HJ, Lee H, Lee HS, Wang SL, Hsueh YM, et al. NAD(P)H: quinone oxidoreductase polymorphism and lung cancer in Taiwan. J Toxicol Environ Health A. 1999;58:187-97.
40. Guo S, Gao M, Li X, Li Y, Chu S, Zhu D, et al. Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PLoS One. 2012;7:e47939.
41. Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M. NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15:979-87.
42. Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, et al. Cigarette smoking and lung cancer-relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012;131:1210-9.
43. Cadenas E. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism. Biochem Pharmacol. 1995;49:127-40.
44. Joseph P, Jaiswal AK. NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA. 1994;91:8413-7.
45. HUGO Pan-Asian SNP Consortium, Abdulla MA, Ahmed I, Assawamakin A, Bhak J, Brahmachari SK, et al. Mapping human genetic diversity in Asia. Science. 2009;326:1541-5.
46. Cai X, Qin Z, Wen B, Xu S, Wang Y, Lu Y, et al. Human migration through bottlenecks from Southeast Asia into East Asia during last glacial maximum revealed by Y chromosomes. PLoS One. 2011;6:e24282.
47. Shi H, Dong YL, Wen B, Xiao CJ, Underhill PA, Shen PD, et al. Y-chromosome evidence of southern origin of the East Asian-specific haplogroup O3-M122. Am J Hum Genet. 2005;77:408-19.
48. Wen B, Li H, Lu D, Song X, Zhang F, He Y, et al. Genetic evidence supports demic diffusion of Han culture. Nature. 2004;431:302-5.
49. Xu S, Yin X, Li S, Jin W, Lou H, Yang L, et al. Genomic dissection of population substructure of Han Chinese and its implication in association studies. Am J Hum Genet. 2009;85:762-74.
50. Cook MB, Dawsey SM, Freedman ND, Inskip PD, Wichner SM, Quraishi SM, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009;18:1174-82.